United States v. Keith Kennedy

CourtCourt of Appeals for the Sixth Circuit
DecidedJanuary 5, 2022
Docket21-2675
StatusUnpublished

This text of United States v. Keith Kennedy (United States v. Keith Kennedy) is published on Counsel Stack Legal Research, covering Court of Appeals for the Sixth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Keith Kennedy, (6th Cir. 2022).

Opinion

NOT RECOMMENDED FOR PUBLICATION File Name: 22a0012n.06

Case No. 21-2675

UNITED STATES COURT OF APPEALS FOR THE SIXTH CIRCUIT

UNITED STATES OF AMERICA, ) FILED ) Jan 05, 2022 ) DEBORAH S. HUNT, Clerk Plaintiff - Appellee, ) ) v. ON APPEAL FROM THE UNITED ) STATES DISTRICT COURT FOR THE ) KEITH KENNEDY, EASTERN DISTRICT OF MICHIGAN ) ) Defendant - Appellant. )

Before: GIBBONS, ROGERS, and NALBANDIAN, Circuit Judges.

GIBBONS, Circuit Judge. Keith Kennedy appeals the district court’s denial of his motion

for reconsideration of compassionate release denial. The district court found that Kennedy’s health

conditions and confinement during the COVID-19 pandemic did not constitute extraordinary and

compelling reasons warranting release, particularly given his refusal to be vaccinated. The district

court did not abuse its discretion by holding that Kennedy lacks extraordinary and compelling

reasons warranting compassionate release. We affirm.

I.

On September 4, 2020, Kennedy was sentenced to 36 months’ imprisonment after pleading

guilty to one count of Conspiracy to Possess with Intent to Distribute Controlled Substances, in

violation of 18 U.S.C. § 846. Kennedy moved for compassionate release on April 6, 2021, arguing

his medical conditions, the global pandemic, his conditions of confinement, and the factors listed

in 18 U.S.C. § 3553(a) warranted release. Kennedy was offered and declined a COVID-19 Pfizer Case No. 21-2675, United States v. Kennedy

vaccine four days before moving for compassionate release. The district court denied Kennedy’s

motion for compassionate release because “his access to the COVID-19 vaccine mitigates the

concern about extraordinary and compelling medical conditions that might otherwise compel

release.” DE 145, Order Denying Compassionate Release, Page ID 981.

Kennedy moved for reconsideration, arguing his reservations about the vaccine are

reasonable, his health conditions warrant release regardless of his vaccination status, and the

vaccine’s efficacy rates for new variants are unknown. The district court noted that under the then-

current local rules, a motion for reconsideration requires the movant to demonstrate a “palpable

defect,” the correction of which will “result in a different disposition of the case.” DE 150, Order

Denying Reconsideration, Page ID 1048. The court denied Kennedy’s motion for reconsideration

because he failed to demonstrate a palpable defect in the court’s order denying his motion for

compassionate release. Kennedy appeals the district court’s order denying his motion for

reconsideration.

II.

A district court’s denial of compassionate release is reviewed for abuse of discretion.

United States v. Jones, 980 F.3d 1098, 1112 (6th Cir. 2020). “A district court abuses its discretion

when it relies on clearly erroneous findings of fact, applies the law improperly, or uses an

erroneous legal standard.” United States v. Pembrook, 609 F.3d 381, 383 (6th Cir. 2010). “Abuse

of discretion is defined as a definite and firm conviction that the trial court committed a clear error

of judgment.” United States v. Flowers, 963 F.3d 492, 497 (6th Cir. 2020) (quoting Landrum v.

Anderson, 813 F.3d 330, 334 (6th Cir. 2016)).

The “compassionate release” provision of the First Step Act, 18 U.S.C. § 3582(c)(1)(A),

allows district courts to reduce incarcerated persons’ sentences in “extraordinary and compelling”

-2- Case No. 21-2675, United States v. Kennedy

circumstances. Jones, 980 F.3d at 1104–06 (discussing the history of compassionate release and

the implementation of the First Step Act). Prior to the First Step Act, the exact contours of what

constituted an “extraordinary and compelling” circumstance warranting release was defined by

U.S.S.G. §1B1.13. Id. at 1108–09. But, in Jones, this court held that “[u]ntil the Sentencing

Commission updates §1B1.13 to reflect the First Step Act, district courts have full discretion in

the interim to determine whether an ‘extraordinary and compelling’ reason justifies compassionate

release when an imprisoned person files a § 3582(c)(1)(A) motion.” Id. at 1109. Section 1B1.13

is yet to be updated, so the district court has discretion to determine whether the “extraordinary

and compelling” threshold has been met.

On appeal, as in the district court, Kennedy claims his “health conditions and confinement

during the COVID-19 pandemic are extraordinary and compelling reasons warranting release”

because the “combination of his conditions has a compounding effect that places him in extremely

serious danger.” CA6 R. 6, Appellant Br., at 12. He argues that “[a]s a 49-year old [sic] obese

Black man with [chronic obstructive pulmonary disease (“COPD”)], sleep apnea, hypertension,

thyroid issues, hepatitis c, and borderline diabetes,” he is particularly susceptible to serious illness

or death if he contracts COVID-19. Id. Kennedy further claims his decision to decline vaccination

is reasonable and does not negate his extraordinary and compelling reasons for release.

The Centers for Disease Control acknowledges that certain underlying medical conditions,

like obesity and COPD, can increase the risk of severe COVID-19. See, e.g., People with Certain

Medical Conditions, Centers for Disease Control (last updated Oct. 14, 2021),

https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-with-medical-

conditions.html. Long-standing systemic health and social inequities, such as those cited by

Kennedy, also put certain minorities at an increased risk of serious illness from COVID-19. See,

-3- Case No. 21-2675, United States v. Kennedy

e.g., id. But these risks can be significantly ameliorated by vaccination, and the district court

correctly explained that “defendants may not perpetuate their own extraordinary and compelling

circumstances for compassionate release by declining [the Bureau of Prison’s] attempt to protect

them.” DE 150, Order Denying Reconsideration, Page ID 1048–49 (relying on January 2021 data

showing that the Pfizer vaccine is 95% effective at preventing COVID-19 in individuals who have

not previously contracted COVID-19).

Kennedy explains his reluctance to receive a vaccine stems from the country’s broader

public health failures in rolling out the vaccine. He points to mixed messaging surrounding the

vaccines’ safety and efficacy, which has led to a lack of vaccination among health care and Bureau

of Prison workers, and to the history of medical experimentation on prisoners and Black

Americans. Kennedy also points to the lack of information in the closed environment in which he

and other incarcerated people live, which makes it particularly difficult to research and make an

informed decision about vaccination. Kennedy also cites the unknown efficacy rates of the

currently available vaccines against new viral variants.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. Pembrook
609 F.3d 381 (Sixth Circuit, 2010)
Lawrence Landrum v. Carl Anderson
813 F.3d 330 (Sixth Circuit, 2016)
United States v. Steven Flowers
963 F.3d 492 (Sixth Circuit, 2020)
United States v. Michael Jones
980 F.3d 1098 (Sixth Circuit, 2020)
United States v. Brian Broadfield
5 F.4th 801 (Seventh Circuit, 2021)
United States v. Michael Lemons
15 F.4th 747 (Sixth Circuit, 2021)

Cite This Page — Counsel Stack

Bluebook (online)
United States v. Keith Kennedy, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-keith-kennedy-ca6-2022.